DJIA 16,677.90 216.58 1.32%
NASDAQ 4,452.79 69.95 1.60%
S&P 500 1,950.82 23.71 1.23%
market minute promo

Novartis (NYSE: NVS)

89.24 1.04 (1.18%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

NVS $89.24 1.18%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $89.15
Previous Close $88.20
Daily Range $88.87 - $89.57
52-Week Range $76.36 - $95.50
Market Cap $216.5B
P/E Ratio 23.84
Dividend (Yield) $2.72 (2.7%)
Ex-Dividend Date
Dividend Pay Date
Volume 1,067,901
Average Daily Volume 1,580,779
Current FY EPS $5.17





Novartis (NVS) Description

Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products. Website:

News & Commentary

Key Takeaways From GlaxoSmithKline's Third-Quarter Earnings

British Pharma GlaxoSmithKline reported third-quarter earnings this morning. Here's what you need to know.

Novartis' Secukinumab Receives Favorable FDA Panel Vote - Analyst Blog

Why Biogen Idec Stock Shares Are Getting Pummeled Today

Biogen Idec shares tumbled more than 10% today on news that a Tecfidera patient was diagnosed with a rare brain disease.

Can Valeant's Strong Q3 Entice Allergan?

European ETFs Plunge As Trouble Hits Region's Core

Can This 1 Breast Cancer Drug Turn Pfizer Inc. Into a Growth Stock?

The world's largest pharmaceutical company, Pfizer, looks lost amid its staggering patent cliff problem. Could this experimental breast cancer drug put Pfizer back on track for growth?

This Drug Could Outsell Medical Marijuana

Three top motley fool analysts weigh in on drugs from Gilead Sciences, Biogen, Bristol-Myers, and Merck that could be bigger sellers than medical marijuana.

Roche Reports Strong Sales Results for 9 Months of 2014 - Analyst Blog

Novartis Presents Encouraging Data on Leukemia Candidate - Analyst Blog

Best European Stock Ideas Today

See More NVS News...

NVS's Top Competitors

NVS $89.24 (1.18%)
Current stock: NVS
MRK $56.63 (2.02%)
Current stock: MRK
PFE $28.60 (1.06%)
Current stock: PFE
GSK $45.36 (2.14%)
Current stock: GSK